Amicus Therapeutics, Inc. (FOLD) Reports Q1 EPS Loss of $0.39
Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q1 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
